患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Authorised

• Phase 3a study to evaluate the efficacy and safety of 4-week treatment of the axillary skin with 1% GPB cream vs placebo and open-label Phase 3b study to assess long-term efficacy and safety in patients with primary axillary hyperhidrosis treated with 1% GPB cream
• Moderate to severe primary axillary hyperhidrosis MedDRA version: 20.0 Level: PT Classification code 10020642 Term: Hyperhidrosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Austria, Denmark, Germany, Hungary, Poland, Sweden, United Kingdom
• 2018-06-20

• Authorised

• FIBRINOGEN AND BLEEDING AFTER CARDIAC SURGERY
• 60 patients undergoing coronary artery bypass surgery MedDRA version: 9.1 Level: LLT Classification code 10011077 Term: Coronary artery bypass
• Sweden
• 2008-02-22

• Authorised

• Tyrosine kinase Inhibitors in DysplAsia of Lung epithelium Study 1 - TIDAL 1 Version 1.0
• High grade dysplasia of the bronchoepithelium MedDRA version: 13.1 Level: PT Classification code 10057004 Term: Bronchial dysplasia System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
• United Kingdom
• 2011-04-27

• Authorised

• "Ensayo clínico piloto, unicéntrico, controlado con placebo, a doble-ciego, aleatorio y cruzado con alfa-1-antitripsina humana en sujetos con fibromialgia". "A single-centre, randomised, double-blind, controlled with placebo, cross-over, pilot clinical trial with human alpha-1-antitrypsin in subjects with fibromyalgia".
• Tratamiento sintomático de la fibromialgia Sintomatic treatment of fibromyalgia MedDRA version: 8.1 Level: LLT Classification code 10048439 Term: Fibromyalgia
• Spain
• 2006-06-28

• Authorised

• Effect on metabolic acidosis due to hyperammonemia of high versus low intake of amino acid in VLBW infants.
• At birth, a VLBW infant is abruptly disconnected from the ideal source of parenteral nutrition - the placenta. If the goal of post-natal nutrition in the VLBW infant is to mimic in utero nutrition. The VLBW infant should be immediately placed on balanced parenteral nutrition. In current praxis parenteral nutrition used to be delayed for several days. MedDRA version: 9.1 Level: LLT Classification code 10063258 Term: Amino acid level
• Germany
• 2007-04-23

• Authorised

• Título completo del ensayo: Estudio fase II de utilización de células dendríticas mieloides autólogas como adyuvante celular para una vacuna terapéutica contra el virus de la inmunodeficiencia tipo 1 en pacientes en estadíos tempranos de la infección por VIH-1.
• Infección por virus de la inmunodeficiencia humana
• Spain
• 2005-10-11

• Authorised

• Phase 3a study to evaluate the efficacy and safety of 4-week treatment of the axillary skin with 1% GPB cream vs placebo and open-label Phase 3b study to assess long-term efficacy and safety in patients with primary axillary hyperhidrosis treated with 1% GPB cream
• Moderate to severe primary axillary hyperhidrosis MedDRA version: 20.0 Level: PT Classification code 10020642 Term: Hyperhidrosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Austria, Denmark, Germany, Hungary, Poland, Sweden, United Kingdom
• 2018-09-27

• Authorised

• Efficay of fibrinogen in liver transplantation
• Liver transplantation is a special risk situation for acute and severe bleeding determined by the complexity of the surgical procedure and by the alteration of haemostasis and coagulation factors, especially fibrinogen, present in the patient affected by a terminal hepatopathy. MedDRA version: 20.0 Level: LLT Classification code 10024716 Term: Liver transplantation System Organ Class: 100000004865 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
• Spain
• 2018-08-07

• Authorised

• Assessment of aspirin response in patients with Type 1 diabetes mellitus: a pilot study
• type 1 diabetes MedDRA version: 14.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
• Italy
• 2012-03-13

• Authorised

• Clinical trial to assess the efficacy of pancreatic enzyme replacement therapy in patients with pancreatic exocrine insufficiency secondary to type 1 diabetes mellitus.
• Patients with pancreatic exocrine insufficiency (PEI) secondary to type 1 diabetes mellitus (DM);Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
• Spain
• 2013-09-16